(Total Views: 532)
Posted On: 12/11/2023 12:09:24 PM
Post# of 148870
"Unexpected high placebo response" scuttles another small biotech's clinical trial.
Amazing how this seems to happen so often to SMALLER biotechs, but not to Big Pharma.
Amazing how this seems to happen so often to SMALLER biotechs, but not to Big Pharma.
Quote:
https://www.fiercebiotech.com/biotech/pharnex...-3-failure
The 387-patient trial did not show that the drug was able to improve functional motor disability as measured by the Overall Neuropathy Limitation Scale (ONLS), the company revealed in a Dec. 11 release. Pharnext blamed an “unexpected” improvement in the disease among the placebo cohort, which it said “complicates the interpretation of the results.”
(3)
(0)Scroll down for more posts ▼
